Holen Sie sich die Stockscreener-App
40.45
1.15%
0.46
Handel nachbörslich:
40.45
Tarsus Pharmaceuticals Inc Aktie (TARS) Neueste Nachrichten
Tarsus Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Tarsus Pharmaceuticals Becomes Oversold (TARS) - Nasdaq
When (TARS) Moves Investors should Listen - news.stocktradersdaily.com
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World
Rhumbline Advisers Increases Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth - Investing.com Australia
Tarsus Pharmaceuticals’ SWOT analysis: XDEMVY’s success propels stock growth By Investing.com - Investing.com India
Insider Sell: Aziz Mottiwala Sells 17,500 Shares of Tarsus Pharm - GuruFocus
Tarsus Pharmaceuticals CCO sells $765,800 in stock - Investing.com Australia
Tarsus Pharmaceuticals CCO sells $765,800 in stock By Investing.com - Investing.com Canada
Certain Common stock of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - marketscreener.com
Certain Stock Options of Tarsus Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 11-JUN-2025. - MarketScreener
Tarsus Pharmaceuticals at Goldman Sachs Conference: Strategic Growth Focus By Investing.com - Investing.com Canada
Transcript : Tarsus Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener
Stocks Showing Improving Market Leadership: Tarsus Pharmaceuticals Earns 87 RS Rating - MSN
Squarepoint Ops LLC Sells 51,329 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Where are the Opportunities in (TARS) - news.stocktradersdaily.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Now Covered by Oppenheimer - Defense World
Oppenheimer Adjusts Price Target on Tarsus Pharmaceuticals to $75 From $72, Maintains Outperform Rating - marketscreener.com
TARS: Oppenheimer Ups Tarsus Pharmaceuticals Price Target to $75 | TARS Stock News - GuruFocus
TARS: Oppenheimer Ups Tarsus Pharmaceuticals Price Target to $75 - GuruFocus
What is HC Wainwright’s Estimate for TARS Q2 Earnings? - Defense World
Nuveen Asset Management LLC Sells 15,186 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus to Participate in Upcoming Investor Conferences | TARS Stock News - GuruFocus
Tarsus Lines Up Triple Conference Appearances: William Blair, Jefferies, and Goldman Sachs in June - Stock Titan
Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Ameriprise Financial Inc. - Defense World
BNP Paribas Financial Markets Buys New Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Stock Rating Upgraded by HC Wainwright - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Now Covered by HC Wainwright - Defense World
TARS: HC Wainwright & Co. Initiates Buy Rating with $72 Target | - GuruFocus
Tarsus Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
TARS: HC Wainwright & Co. Initiates Buy Rating with $72 Target | TARS Stock News - GuruFocus
TARS: H.C. Wainwright Initiates Coverage with a Buy Rating | TARS Stock News - GuruFocus
Tarsus Pharmaceuticals Advances Novel Treatments for Eye and Vector-Borne Diseases - utahdailynewswire.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $1.16 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Purchased by Bank of America Corp DE - Defense World
Tarsus Pharmaceuticals at H.C. Wainwright: Expanding Horizons with Xdemvy By Investing.com - Investing.com Canada
Tarsus Pharmaceuticals Shows Rising Price Performance With Jump To 84 RS Rating - inkl
When the Price of (TARS) Talks, People Listen - news.stocktradersdaily.com
Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Tarsus Pharmaceuticals Inc Enters Oversold Territory (TARS) - Nasdaq
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Acquired by Northern Trust Corp - Defense World
Transcript : Tarsus Pharmaceuticals, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 03 - marketscreener.com
Tarsus Pharmaceuticals Breaks Below 200-Day Moving AverageNotable for TARS - Nasdaq
Tarsus Pharmaceuticals (TARS) Expected to Announce Earnings on Wednesday - Defense World
Tarsus Pharmaceuticals: The "Get Big Fast" Approach Could Pay Off (NASDAQ:TARS) - Seeking Alpha
Tarsus to Participate in Upcoming Investor Conferences | TARS St - GuruFocus
Dimensional Fund Advisors LP Sells 62,658 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals Reports First Quarter 2025 Sales Growth - VisionMonday.com
1.45%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):